By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Yuki Joins AWS ISV Accelerate (ISVA) Program to Bring Real-Time Data Cost Control to AI Workloads on Snowflake
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > Yuki Joins AWS ISV Accelerate (ISVA) Program to Bring Real-Time Data Cost Control to AI Workloads on Snowflake
Yuki Joins AWS ISV Accelerate (ISVA) Program to Bring Real-Time Data Cost Control to AI Workloads on Snowflake
Technology

Yuki Joins AWS ISV Accelerate (ISVA) Program to Bring Real-Time Data Cost Control to AI Workloads on Snowflake

GlobeNews Wire
Last updated: 09/02/2026 6:37 PM
GlobeNews Wire
Published: 09/02/2026
Share
SHARE

TEL AVIV, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) — Yuki, the real-time orchestration platform for cloud data warehouses, today announced it has joined the Amazon Web Services (AWS) ISV Accelerate (ISVA) Program, a global co-sell program for AWS Partners who provide software solutions that run on or integrate with AWS and sell through AWS Marketplace.

As organizations deploy GenAI and LLM applications, they need to manage variable data workloads, with pipelines for embeddings, retrieval, evaluation, and agent-driven analytics layered on top of existing BI and ETL. Yuki enhances their ability to manage performance for these workloads while forecasting spend.

Yuki acts as the orchestration layer for Snowflake and BigQuery compute. It continuously interprets workload signals and automatically routes queries, right-sizes resources, and consolidates capacity in real time, reducing operational drag without trading off performance.

Last year, customers saved 42% on average, with onboarding in under an hour. As AI workloads increasingly span multiple data platforms, Yuki plans to expand support to additional environments, including Databricks, later this year.

The ISVA Program provides co-sell support and benefits that help AWS sellers engage with participating partners to drive joint customer outcomes, including collaboration with AWS field sellers globally.

“Most teams don’t have a tooling problem, they have a control problem,” said Perry Tapiero, Head of Marketing and GTM at Yuki. “AI-era data stacks make compute spiky and harder to govern, especially as pipelines multiply across teams. Yuki automatically routes workloads and right-sizes Snowflake and BigQuery in real time to improve performance and make spend predictable. ISVA helps us scale that value with AWS sellers and deliver faster outcomes for joint customers.”

Yuki is available in AWS Marketplace, enabling customers to procure through existing AWS agreements and streamline deployment. To learn more, visit Yuki in AWS Marketplace.

About Yuki

Yuki is a control platform for cloud data warehouses. Yuki automatically routes workloads and right-sizes compute across Snowflake and Google BigQuery to improve performance and make spend predictable. Yuki deploys privately in your environment with enterprise-grade governance and controls.

Media Contact
Orian Tal
The Pitch
orian@thepitch.media

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/f30df35f-8030-4346-a0bf-e85f523439d6

Linglong Tire’s 50th Anniversary Celebration Kicks Off in London
Junshi Biosciences Announces Primary Endpoints Met in JS001scs Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference
GAC Accelerates European Market Plan, Partnering with Magna to Deepen Localized Cooperation
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
TAGGED:(isva)accelerateawsbringcontrolcostdataisvjoinsnewsprogramreal-timesnowflakeworkloadsyuki
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Huawei Launched Global Intelligent Public Service Solution to Accelerate Intelligent Transformation of Public Services and City Governance
News

Huawei Launched Global Intelligent Public Service Solution to Accelerate Intelligent Transformation of Public Services and City Governance

06/03/2026
IOC announces integrity measures ahead of Milano Cortina 2026
Fermenta FY25 Revenues INR 481.3 cr, up 39% YoY; Net Profit INR 76.4 cr vs year-ago loss
Market Logic Software launches DeepSights Persona Agents: Turning customer data into interactive conversations
Pickleball Kingdom Goes International with India Expansion
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?